Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer.

Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer.
Mol Clin Oncol. 2019 May;10(5):497-505
Authors: Xiu Y, Liu W, Wang T, Liu Y, Ha M
Abstract
Epithelial cell transforming sequence 2 (ECT2) is a guanine nucleotide exchange factor encoded by the ECT2 gene, which is located on the 3q26.31 chromosomal region and is directly associated with the occurrence of cancers. The aim of the present study was to examine the expression and prognostic importance of ECT2 in various breast cancer subtypes using the online tools, Gene Expression Profiling Interactive Analysis, Kaplan-Meier-plotter and bc-GenExMiner. ECT2 mRNA expression was significantly different in oestrogen receptor ER(+) breast cancer; overexpression of ECT2 was associated with poor prognosis in ER+ breast cancer. The mRNA expression levels of ECT2 were increased in basal-like breast cancer and triple negative breast cancer, but were not significant for prognostic prediction. We identified ECT2-correlated genes and their corresponding Gene Ontology (GO) enrichment terms. The results revealed that GO: 0005524 (protein binding) had the greatest number of correlated genes and also contained ECT2. This suggested that overexpression of ECT2 may be a significant prognostic factor for poor outcome in ER+ breast cancer; however, the precise role of ECT2 in breast cancer requires further investigation.
PMID: 30967944 [PubMed]

Source: Clinical Breast Cancer - April 12, 2019 Category: Cancer & Oncology Authors: Xiu Y, Liu W, Wang T, Liu Y, Ha M Tags: Mol Clin Oncol Source Type: research